Global Multivalent Vaccines Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Multivalent Vaccines

• 1.1 Definition of Multivalent Vaccines
• 1.2 Multivalent Vaccines Segment by Type
  • 1.2.1 Global Multivalent Vaccines Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Conjugate Vaccines
  • 1.2.3 Inactivated and Subunit Vaccines
  • 1.2.4 Live Attenuated Vaccines
  • 1.2.5 Toxoid Vaccines
  • 1.2.6 Recombinant Vaccines
• 1.3 Multivalent Vaccines Segment by Applications
  • 1.3.1 Global Multivalent Vaccines Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Pediatrics
  • 1.3.3 Adults
• 1.4 Global Multivalent Vaccines Overall Market
  • 1.4.1 Global Multivalent Vaccines Revenue (2014-2025)
  • 1.4.2 Global Multivalent Vaccines Production (2014-2025)
  • 1.4.3 North America Multivalent Vaccines Status and Prospect (2014-2025)
  • 1.4.4 Europe Multivalent Vaccines Status and Prospect (2014-2025)
  • 1.4.5 China Multivalent Vaccines Status and Prospect (2014-2025)
  • 1.4.6 Japan Multivalent Vaccines Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Multivalent Vaccines Status and Prospect (2014-2025)
  • 1.4.8 India Multivalent Vaccines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Multivalent Vaccines
• 2.3 Manufacturing Process Analysis of Multivalent Vaccines
• 2.4 Industry Chain Structure of Multivalent Vaccines

3 Development and Manufacturing Plants Analysis of Multivalent Vaccines

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Multivalent Vaccines Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Multivalent Vaccines
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Multivalent Vaccines Production and Capacity Analysis
• 4.2 Multivalent Vaccines Revenue Analysis
• 4.3 Multivalent Vaccines Price Analysis
• 4.4 Market Concentration Degree

5 Multivalent Vaccines Regional Market Analysis

• 5.1 Multivalent Vaccines Production by Regions
  • 5.1.1 Global Multivalent Vaccines Production by Regions
  • 5.1.2 Global Multivalent Vaccines Revenue by Regions
• 5.2 Multivalent Vaccines Consumption by Regions
• 5.3 North America Multivalent Vaccines Market Analysis
  • 5.3.1 North America Multivalent Vaccines Production
  • 5.3.2 North America Multivalent Vaccines Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Multivalent Vaccines Import and Export
• 5.4 Europe Multivalent Vaccines Market Analysis
  • 5.4.1 Europe Multivalent Vaccines Production
  • 5.4.2 Europe Multivalent Vaccines Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Multivalent Vaccines Import and Export
• 5.5 China Multivalent Vaccines Market Analysis
  • 5.5.1 China Multivalent Vaccines Production
  • 5.5.2 China Multivalent Vaccines Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Multivalent Vaccines Import and Export
• 5.6 Japan Multivalent Vaccines Market Analysis
  • 5.6.1 Japan Multivalent Vaccines Production
  • 5.6.2 Japan Multivalent Vaccines Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Multivalent Vaccines Import and Export
• 5.7 Southeast Asia Multivalent Vaccines Market Analysis
  • 5.7.1 Southeast Asia Multivalent Vaccines Production
  • 5.7.2 Southeast Asia Multivalent Vaccines Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Multivalent Vaccines Import and Export
• 5.8 India Multivalent Vaccines Market Analysis
  • 5.8.1 India Multivalent Vaccines Production
  • 5.8.2 India Multivalent Vaccines Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Multivalent Vaccines Import and Export

6 Multivalent Vaccines Segment Market Analysis (by Type)

• 6.1 Global Multivalent Vaccines Production by Type
• 6.2 Global Multivalent Vaccines Revenue by Type
• 6.3 Multivalent Vaccines Price by Type

7 Multivalent Vaccines Segment Market Analysis (by Application)

• 7.1 Global Multivalent Vaccines Consumption by Application
• 7.2 Global Multivalent Vaccines Consumption Market Share by Application (2014-2019)

8 Multivalent Vaccines Major Manufacturers Analysis

• 8.1 GlaxoSmithKline, plc (U.K.)
  • 8.1.1 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Production Sites and Area Served
  • 8.1.2 GlaxoSmithKline, plc (U.K.) Product Introduction, Application and Specification
  • 8.1.3 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Pfizer, Inc. (U.S.)
  • 8.2.1 Pfizer, Inc. (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 8.2.2 Pfizer, Inc. (U.S.) Product Introduction, Application and Specification
  • 8.2.3 Pfizer, Inc. (U.S.) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Merck & Co., Inc. (U.S.)
  • 8.3.1 Merck & Co., Inc. (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 8.3.2 Merck & Co., Inc. (U.S.) Product Introduction, Application and Specification
  • 8.3.3 Merck & Co., Inc. (U.S.) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Sanofi Pasteur SA (France)
  • 8.4.1 Sanofi Pasteur SA (France) Multivalent Vaccines Production Sites and Area Served
  • 8.4.2 Sanofi Pasteur SA (France) Product Introduction, Application and Specification
  • 8.4.3 Sanofi Pasteur SA (France) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Astellas Pharma Inc. (Japan)
  • 8.5.1 Astellas Pharma Inc. (Japan) Multivalent Vaccines Production Sites and Area Served
  • 8.5.2 Astellas Pharma Inc. (Japan) Product Introduction, Application and Specification
  • 8.5.3 Astellas Pharma Inc. (Japan) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 CSL Limited (Australia)
  • 8.6.1 CSL Limited (Australia) Multivalent Vaccines Production Sites and Area Served
  • 8.6.2 CSL Limited (Australia) Product Introduction, Application and Specification
  • 8.6.3 CSL Limited (Australia) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Emergent BioSolutions, Inc. (U.S.)
  • 8.7.1 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 8.7.2 Emergent BioSolutions, Inc. (U.S.) Product Introduction, Application and Specification
  • 8.7.3 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Johnson & Johnson (U.S.)
  • 8.8.1 Johnson & Johnson (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 8.8.2 Johnson & Johnson (U.S.) Product Introduction, Application and Specification
  • 8.8.3 Johnson & Johnson (U.S.) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 MedImmune, LLC (U.S.)
  • 8.9.1 MedImmune, LLC (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 8.9.2 MedImmune, LLC (U.S.) Product Introduction, Application and Specification
  • 8.9.3 MedImmune, LLC (U.S.) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Serum Institute of India Pvt. Ltd. (India)
  • 8.10.1 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Production Sites and Area Served
  • 8.10.2 Serum Institute of India Pvt. Ltd. (India) Product Introduction, Application and Specification
  • 8.10.3 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Bavarian Nordic (Denmark)
• 8.12 Mitsubishi Tanabe Pharma Corporation (Japan)
• 8.13 Daiichi Sankyo (Japan)
• 8.14 Protein Sciences Corporation (U.S.)
• 8.15 Panacea Biotec (India)

9 Development Trend of Analysis of Multivalent Vaccines Market

• 9.1 Global Multivalent Vaccines Market Trend Analysis
  • 9.1.1 Global Multivalent Vaccines Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Multivalent Vaccines Regional Market Trend
  • 9.2.1 North America Multivalent Vaccines Forecast 2019-2025
  • 9.2.2 Europe Multivalent Vaccines Forecast 2019-2025
  • 9.2.3 China Multivalent Vaccines Forecast 2019-2025
  • 9.2.4 Japan Multivalent Vaccines Forecast 2019-2025
  • 9.2.5 Southeast Asia Multivalent Vaccines Forecast 2019-2025
  • 9.2.6 India Multivalent Vaccines Forecast 2019-2025
• 9.3 Multivalent Vaccines Market Trend (Product Type)
• 9.4 Multivalent Vaccines Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Multivalent Vaccines Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List